Featured Study: PRIME Care

INVESTIGATING THE USE OF PRECISION MEDICINE TO TREAT DEPRESSION

FROM NOTEWORTHY PUBLICATIONS- SPRING 2018

Dr. David Oslin, a researcher at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, is testing the use of genetic information to tailor drug therapies for Veterans with major depression. VA Health Services Research and Development and VA's Genomic Medicine Implementation programs are funding a study of precision medicine's role in improving treatment for Veterans with major depressive disorder.

The initiative, PRIME Care (PRecision medicine In MEntal health Care), is led by Dr. David Oslin of the Corporal Michael J. Crescenz VA Medical Center in Philadelphia. It is scheduled to run through June 2022 at more than 20 VA sites across the nation. Click here to read more.